A general AIDS/HIV thread

All info related to the new biggest hoax of our time.
User avatar
Unreal
Posts: 166
Joined: Sun Jan 24, 2021 8:06 am
Has thanked: 237 times
Been thanked: 226 times

Re: A general AIDS/HIV thread

Unread post by Unreal »

" The scientific consensus is that the evidence showing HIV to be the cause of AIDS is conclusive and that HIV/AIDS denialist claims are pseudoscience based on conspiracy theories, faulty reasoning, cherry picking, and misrepresentation of mainly outdated scientific data " - wiki
-
The notion of "scientific consensus" is interesting and for most most of us quite convincing. Much of the magic in all medical fraud does require such medical consensus, hence a large part of the trick is how this is actually achieved. It's very clear that most if not all research originates or at least is controlled by schools and universities. And education is mostly gouverned by obscure parts of the state, big money and "charity" - or at least have very influential schoolboards.
-
Scientific consensus is achieved through scholarly communication at conferences, the publication process, replication of reproducible results by others, scholarly debate, and peer review. Consensus generally implies agreement of the supermajority*, though not necessarily unanimity. -wiki

* supermajority is a requirement for a proposal to gain a specified level of support greater than a half as in the habitual, simple majority. Like two-thirds (66.6%), three-fifths (60%) or even just 55%.
User avatar
rachel
Posts: 3769
Joined: Thu Oct 11, 2018 9:04 pm
Location: Liverpool, England
Has thanked: 1312 times
Been thanked: 1611 times

Ebola Citations

Unread post by rachel »

Some medical Citations, usual suspects

https://www.researchgate.net/figure/Ebo ... _279058570
May 2015
In 2014, Ebola virus outbreak spread from Guinea, Liberia and Sierra Leone. It had spread rapidly since early 2014 and the frequency was higher in the late December, but currently situation is becoming normal now. Ebola Outbreak of 2014 had proved to be more deadly than that of previously known epidemics. Till 24th October 2014, there have been 10,141 confirmed cases with 4,922 deaths and then it has reached to 27,049 cases and 11,149 deaths till 24th May 2015. No vaccine could be developed to halt the epidemic and disease was spreading to larger areas. World Health Organization undertook immediate action plan to launch vaccines after proper clinical trials. Multiple experimental vaccines were proposed with higher efficiency in in vivo experimental models but with uncertainties for their human use. There are multiple reasons for the rapid spread of this virus and due to high mutational variations in its genome brought about a bigger challenge between experimental vaccines, which worked well on animals but uncertain in humans. The article highlights some immense controversies and hurdles that different research group pertain to come for eradication of Ebola since December 2013. There is a hope that soon there will be an effective vaccine against EBOV which will greatly help to manage any future Ebola outbreak.

Ebola-Vaccines-being-developed-and-tested-along-with-location.png

https://www.researchgate.net/publicatio ... 9_patients
A review of medications used to control and improve the signs and symptoms of COVID-19 patients

Abstract
In December 2019, an unprecedented outbreak of pneumonia associated with a novel coronavirus disease 2019 (COVID-19) emerged in Wuhan City, Hubei province, China. The virus that caused the disease was officially named by the World Health Organization (WHO) as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the high transmission rate of SARS-CoV-2, it became a global pandemic and public health emergency within few months. Since SARS-CoV-2 is genetically 80% homologous with the SARS-CoVs family, it is hypothesized that medications developed for the treatment of SARS-CoVs may be useful in the control and management of SARS-CoV-2. In this regard, some medication being tested in clinical trials and in vitro studies include anti-viral RNA polymerase inhibitors, HIV-protease inhibitors, anti-inflammatory agents, angiotensin converting enzyme type 2 (ACE 2) blockers, and some other novel medications. In this communication, we reviewed the general characteristics of medications, medical usage, mechanism of action, as well as SARS-CoV-2 related trials.

https://www.researchgate.net/figure/Thi ... _281904382
... During west Africa Ebola virus outbreak, one study reported that favipiravir was effective in improvement of an Ebola infected nurse (Trompiz et al., 2014). The results of a clinical trial that was conducted in Guéckédou, Guinea (December 2014) showed a decline in mortality rate in Ebola infected patients in low to moderate levels of the disease but with no effect on severe form (Fink, 2015;Grobusch-mp, 2015). • SARS-CoV-2: Since February 2020, favipiravir has been studied in drug repurposing program for the treatment of SARS-CoV-2 pandemic (Li and De Clercq, 2020). ...
Post Reply